Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholic Acid Continuation Study for Bile Acid Synthesis Defects
NCT01438411Phase 3Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Jan 2010
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cholic acid in inborn errors of bile acid synthesis, sponsored by Mirum Pharmaceuticals, Inc.. Started Jan 2010; status: completed.
02
Drugs
cholic acid
03
Conditions
inborn errors of bile acid synthesis
Beyond the preview
Go deeper on NCT01438411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438411.